Latest Articles
Boryung clears lenvatinib monotherapy patents, targets Korea combo-therapy fight - CHOSUNBIZ - Chosunbiz
Boryung clears lenvatinib monotherapy patents, targets Korea combo-therapy fight - CHOSUNBIZ Chosunbiz
Published: Aug. 18, 2026, 9:03 p.m.
Faeth Therapeutics (FTH) Gains FDA Fast Track for Endometrial Cancer Combo Therapy - GuruFocus
Faeth Therapeutics (FTH) Gains FDA Fast Track for Endometrial Cancer Combo Therapy GuruFocus
Published: Aug. 17, 2026, 12:03 p.m.
Tell Me About Oestra for Menopause Hormone Therapy? - Dr. Jen Gunter | Substack
Tell Me About Oestra for Menopause Hormone Therapy? Dr. Jen Gunter | Substack
Published: Aug. 14, 2026, 12:53 a.m.
Dr Silverstein on the Efficacy of Abemaciclib and Hormonal Therapy in Recurrent Ovarian and Endometrial Cancer - OncLive
Dr Silverstein on the Efficacy of Abemaciclib and Hormonal Therapy in Recurrent Ovarian and Endometrial Cancer OncLive
Published: Aug. 12, 2026, 3:24 a.m.
Pembrolizumab Monotherapy Beats Chemotherapy in Front-Line dMMR Endometrial Cancer - Clinical Oncology News
Pembrolizumab Monotherapy Beats Chemotherapy in Front-Line dMMR Endometrial Cancer Clinical Oncology News
Published: Aug. 3, 2026, 3:32 p.m.
Pembrolizumab Monotherapy Beats Chemotherapy in Front-Line dMMR Endometrial Cancer - clinicaloncology.com
Pembrolizumab Monotherapy Beats Chemotherapy in Front-Line dMMR Endometrial Cancer clinicaloncology.com
Published: Aug. 3, 2026, 3:31 p.m.
Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial - Yahoo Finance
Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial Yahoo Finance
Published: July 27, 2026, 10:08 p.m.
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer - CancerNetwork
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer CancerNetwork
Published: July 16, 2026, 3:40 p.m.
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer - Sahm
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer Sahm
Published: July 16, 2026, 10:27 a.m.
Merck's (MRK) Keytruda Becomes First PD-1 Inhibitor To Beat Chemotherapy Alone In Endometrial Cancer Subtype - londoninsider.co.uk
Merck's (MRK) Keytruda Becomes First PD-1 Inhibitor To Beat Chemotherapy Alone In Endometrial Cancer Subtype londoninsider.co.uk
Published: July 15, 2026, 11:49 p.m.
Link copied to clipboard!